Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.

Sweeney CJ, Takimoto CH, Latz JE, Baker SD, Murry DJ, Krull JH, Fife K, Battiato L, Cleverly A, Chaudhary AK, Chaudhuri T, Sandler A, Mita AC, Rowinsky EK.

Clin Cancer Res. 2006 Jan 15;12(2):536-42.

2.

A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.

Sandler A, Gordon M, De Alwis DP, Pouliquen I, Green L, Marder P, Chaudhary A, Fife K, Battiato L, Sweeney C, Jordan C, Burgess M, Slapak CA.

Clin Cancer Res. 2004 May 15;10(10):3265-72.

3.

Dramatic response of teratoma-associated non--germ-cell cancer with all-trans retinoic acid in a patient with nonseminomatous germ cell tumor.

Gordon MS, Battiato LA, Finch D, Goulet R Jr, Einhorn LH.

Am J Clin Oncol. 2001 Jun;24(3):269-71.

PMID:
11407397
4.

Oprelvekin: an alternative treatment for thrombocytopenia.

Rust DM, Wood LS, Battiato LA.

Clin J Oncol Nurs. 1999 Apr;3(2):57-62.

PMID:
10633612
5.

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.

Clin Cancer Res. 1997 Mar;3(3):409-17.

6.

Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.

Orazi A, Cooper RJ, Tong J, Gordon MS, Battiato L, Sledge GW Jr, Kaye JA, Kahsai M, Hoffman R.

Exp Hematol. 1996 Sep;24(11):1289-97.

PMID:
8862439
7.

A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.

Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW Jr.

Blood. 1996 May 1;87(9):3615-24.

PMID:
8611685
8.

A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma.

Gordon MS, Battiato LA, Gonin R, Harrison-Mann BC, Loehrer PJ Sr.

J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):179-84.

PMID:
8770773
9.

A high school nurse mentorship project.

Walsh MB, Battiato LO.

Nurs Manage. 1994 Aug;25(8):82-3. No abstract available.

PMID:
8065691

Supplemental Content

Loading ...
Support Center